SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : TGL WHAAAAAAAT! Alerts, thoughts, discussion.

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Harbie who wrote (106456)6/10/2002 2:47:10 PM
From: Jim Bishop   of 150070
 
Jun 10, 2002 (Herald Sun - ABIX via COMTEX) -- Researchers from the Victorian
College of Pharmacy and Monash University have developed a new drug delivery
method. A metered dose of medication mixed with an enhancer to aid absorption is
sprayed onto a patient's arm. The liquid is then absorbed into the bloodstream.
The system has already been successfully tested at Melbourne's Jean Haile
Foundation, where it was shown it could deliver doses as part of hormone
replacement therapy. It is also believed spray-on drugs could be suitable for
relieving travel sickness and delivering contraceptives and nicotine
replacements. Drugs to treat Parkinson's and Alzheimer's diseases could also
potentially be delivered via this method. One particular benefit of the system
is that it permits doses to be varied. The company, Acrux, has been established
to develop the drug delivery system.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext